Vizcaldix

Roman name

Viskaldix

Pharmacokinetics

Completely absorbed from the digestive tract. Metabolised equally liver, and kidneys. Linking blood plasma pindolola - 40-60%, klopamida-46%. T_1/2 pindolola, 3-4 p, klopamida-6 pm Write mainly kidneys.

Indications

Arterial hypertension (monotherapy or in combination with other antigipertenzivei means).

Pregnancy and lactation

Not recommended. At the time of treatment should stop breastfeeding.

Contraindications

Hypersensitivity, glomerulonefrit acute, severe kidney and / or liver failure, chronic heart failure, refrakternaya to treat cardiac glycosides, lung heart, aetiology, AV blockade II and III extent syndrome weakness sinusnogo unit gipercalziemia, gipokaliemia, bronchial asthma planned surgery under general anaesthesia (using ether or chloroform), Addison disease, pregnancy and breastfeeding (not recommended), a children's age (experience of the missing).

Patient interaction

Increases lithium concentration in the blood, reduces (mutually) effect simpatomimetikov, tricyclic antidepressants, anti proximity and MAO inhibitors increases (mutually) - simpatolitikov, vazodilatatorov peripheral. It may mask the symptoms gipoglikemii in appointing protivodiabeticakih pills and insulin.

Precautions

Be wary appoint patients diabetes or during prolonged starvation (to avoid gipoglikemii; Dose of antidiabetics, including insulin, it should be cash). There is a need to monitor the level of potassium whey with circulatory failure, kidney and liver failure. In chronic heart failure treatment were available only in combination with traditional therapy. When gaseous CO2 in the history should be monitored gemodinamicakie indicators. The patients prone to bronhospazmu and obstructive respiratory diseases, in some cases, it can cause asthma attack (in the case of arthritis treatment should cease immediately). Denial of drug dose should be reduced gradually (to avoid deterioration of the patient, especially when details). Patients feohromotsytoma appoint, in conjunction with альфа-адреноблокатор��ми. The treatment can increase the human peripheral blood circulation. Be wary of during the drivers of vehicles and people skills relate to the high concentration of attention.

Dosing and Administration

Inside-1 table. morning (at the luncheon). If, in the course of 1-2 weeks has not brought about the desired gipotenzivnogo effect dose can be increased to 2-3 table. per day. Daily dose of three table encouraged to undertake separately on the table 1.5. twice a day (morning and afternoon).

Storage conditions

List B. In the dark place at a temperature of 15-25 ° C

Shelf life

5 years

The registration

013484/01-2001

Directory → Organotropona funds → The governing bodies of the urinary and reproduction → Dioretiki → Vizcaldix